IMPLICATIONS OF NEOADJUVANT CHEMOTHERAPY ON COST AND OUTCOMES IN MUSCLE INVASIVE BLADDER CANCER

dc.contributor.author	Woldu, Solomon
dc.contributor.author	Clinton, Timothy
dc.contributor.author	Raj, Ganesh
dc.contributor.author	Sagalowsky, Arthur
dc.contributor.author	Margulis, Vitaly
dc.contributor.author	Lotan, Yair
dc.contributor.author	Gianni, Louis
dc.contributor.author	Wang, Richard
dc.contributor.author	ŞANLI, Mehmet Öner
dc.date.accessioned	2022-02-18T09:58:37Z
dc.date.available	2022-02-18T09:58:37Z
dc.identifier.citation	Clinton T., Woldu S., ŞANLI M. Ö. , Wang R., Gianni L., Raj G., Sagalowsky A., Margulis V., Lotan Y., "IMPLICATIONS OF NEOADJUVANT CHEMOTHERAPY ON COST AND OUTCOMES IN MUSCLE INVASIVE BLADDER CANCER", American-Urological-Association(AUA) Annual Meeting, San-Francisco, Kostarika, 18 - 21 Mayıs 2018, cilt.199
dc.identifier.other	av_6f8ad7d2-93e3-4cfe-98a7-702951eeb413
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/178341
dc.language.iso	eng
dc.subject	Tıp
dc.subject	ÜROLOJİ VE NEFROLOJİ
dc.subject	Klinik Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Health Sciences
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Nefroloji
dc.subject	Nephrology
dc.subject	Urology
dc.title	IMPLICATIONS OF NEOADJUVANT CHEMOTHERAPY ON COST AND OUTCOMES IN MUSCLE INVASIVE BLADDER CANCER
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	199
dc.contributor.firstauthorID	3386185

Files in this item

Files	Size	Format	View
There are no files associated with this item.